Abstract Context: In recent years phosphodiesterase V acts as an attractive target for cardiovascular drug design and QSAR techniques are helpful for the optimization of structural requirements for designing novel compounds.
Introduction
Phosphodiesterase enzymes catalyze the conversion of cyclic GMP and cyclic AMP into the corresponding nucleotide monophosphates with the emergence of molecules like sildenafil and tadalafil. The phosphodiesterase 5 (PDE5) inhibition is now emerged as the most favorite tool for the treatment of erectile dysfunction in men. Large amount of research is carried out for the identification of new, selective PDE5 inhibitors and to investigate their usefulness in cardiovascular disorders to act as vascular smooth muscle relaxants. In human PDE5 is frequently observed in lungs, platelets, and vascular smooth muscles. PDE5 is specific for the cGMP, in its both catalytic sites, and in the two cGMP-binding allosteric sites (Sausbier et al., 2000; McAllister-Lucas et al., 1993; Chang et al., 2010; Tollefson et al., 2010; Yang et al., 2006) . In PDE5 there are two cGMP-binding domains: (i) an N-terminal domain harboring a site for phosphorylation and (ii) a C-terminal catalytic domain of the enzyme (Chen et al., 2009 (Chen et al., , 2008 Matsumoto et al., 2003; Reffelmann and Kloner, 2009; Guazzi, 2008; Palmer et al., 2007; Srivani et al., 2007; Rotella, 2002) . The catalytic domain of PDE5 is constituted by four major parts which includes three helical subdomains, an N-terminal cyclin-fold region, a linker region and a C-terminal helical bundle. The present communication deals with 3D QSAR (Fegade et al., 2009; Jhaa et al., 2009; Sharma and Sharma, 2010) analysis of 1-(2-ethoxyethyl)-1H-pyrazolo [4,3-d] pyrimidines derivatives by multiple linear regression and k-nearest neighbor molecular field analysis (kNN-MFA) for the designing of new phosphodiesterase 5 inhibitors with vascular smooth muscle relaxant activity.
Computational details

Dataset
A dataset of 33 compounds was taken from the published phosphodiesterase V inhibitors by Tollefson et al. (2010) . The structures and their inhibitory activities are listed in Table 1. The inhibitory activity IC50 values were converted into the corresponding pIC50 (log 1/IC50) and used as dependent variables in the 3D-QSAR analyses. The whole dataset was Table 1 The molecules under study. randomly divided into a training set of 28 compounds and a test set of 5 compounds (asterisked molecules in Table 1 ). The training set was used to construct the 3D-QSAR models and the test set was used for the models validation.
Materials and methods
Ligand preparation
The structure of substituted derivatives was used as the template to 1-(2-ethoxyethyl)-1H-pyrazolo [4,3-d] pyrimidines built molecules in the dataset in Vlife MDS 3.5. All the structures were minimized using the standard Merck molecular force field (MMFF) with the distance dependant dielectric function and an energy gradient of 0.001 kcal/mol Å .
Molecular alignment
The molecules of the dataset were aligned by the template based technique, using the common structure of 1-(2-ethoxy-
The alignment of all the molecules on the template is shown in Fig. 1 .
Descriptor calculation
Like many 3D-QSAR methods, a suitable alignment of given set of molecules was performed using the Vlife MDS 3.5 Engine. This was followed by the generation of a common rectangular grid around the molecules. The hydrophobic, steric and electrostatic interaction energies are computed at the lattice points of the grid using a methyl probe of charge +1. These interaction energy values are considered for relationship generation and utilized as descriptors to decide the nearness between molecules. The term descriptor is utilized in the following discussion to indicate the field values at the lattice points.
3D-QSAR studies using multiple linear regressions
Stepwise multiple regression (SMR) is a systematic approach for selecting useful variable and generating models. Stepwise forward-backward method from Vlife MDS was used as a variable selection method, with a cross correlation limit of 0.7 to eliminate highly inter-correlated variables and a variance cutoff of 0.5 to eliminate insignificant variables.
3D-QSAR studies using kNN-MFA
The calculated fields of randomly selected 28 molecules used in the training set were considered as observations to generate the QSAR model using a stepwise variable selection (SW) kNN-MFA method. Plot of the kNN-MFA which shows the relative position and ranges of the corresponding important electrostatic/steric fields in the model provides the following guidelines for the design of new molecules.
2.4.1. kNN-MFA with stepwise variable selection method This method employs the kNN classification principle combined with the stepwise variable selection procedure for the optimization of:
(i) The number of nearest neighbors (k) used to estimate the activity of each compound (ii) Selection of variables from the original pool of all molecular descriptors (steric and electrostatic field at the lattice points) that are used to calculate the similarities between compounds (i.e., distances in near-dimensional descriptor space).
Further, a step-by-step search procedure that begins by developing a hypothetical pharmacophore (HP model) with a single independent variable and adds independent variables Figure 1 The alignment of molecules. Figure 2 Field point for 3D-QSAR model A.
3D QSAR, pharmacophore indentification studiesone step at a time, examining the fit of the model at each step (using weighted k-nearest neighbor cross validation procedure) until there are no more significant variables remaining outside the model is included.
Pharmacophore modeling
Pharmacophore modeling was carried out using the MolSign module of Vlife MDS 3.5 software. Series of phosphodiesterase V inhibitors were first aligned on the active molecule. A pharmacophore model is a set of three-dimensional features that are necessary for bioactive ligands. Thus, it makes logical sense to align molecules based on the features that are responsible for bioactivity. The software was set to generate minimum four pharmacophoric features obtained keeping the tolerance limit at 10 Å . The maximum distance of 10 Å was kept between two features in pharmacophore identification studies. The average RMSD of the pharmacophore alignments of each two molecules is 0.055.
Results
In the present study, 28 molecules were used in the training set (Table 1 ) to derive kNN-MFA 3D-QSAR models with the number of field grid points being not more than seven per model. To evaluate the predictive ability of generated 3D-QSAR models, a test set of 5 molecules with regularly distributed biological activities was used (Table 1) . On successful runs of MLR and kNN-MFA, different sets of equations were generated and these equations were further analyzed statistically to select the best model, as shown in Table 2 , two models were selected after screening various combinations of different descriptors.
Discussion
Interpretation of 3QSAR model (MLR)
The optimum structural requirements of pyrazolo [4,3-d] pyrimidines analogs for phosphodiesterase V inhibitors were obtained in the form of the 3D descriptors of model A (Mbarki et al., 2011) . The r 2 value for model A was 0.93 (Fig 2) . Model A shows the first model which is selected on the basis of statistical coefficients like r 2 (0.93) and Pred r 2 (0.89). The contributing descriptors for model A are E_950, S_304, E_1021, E_941 and S_1051 which are nothing but the electrostatic and steric interactions at that lattice point. The electrostatic interaction at the lattice points E_950 and E_1021 is negatively contributing that means the substitution of electron withdrawing groups on the aromatic ring at r 2 can yield potent phosphodiesterase V inhibitors, also the steric interaction at the lattice point 304 is also negatively contributing that means the substitution at the R1 should be small, the increase in chain length could decrease the activity. The electrostatic interaction at the lattice point 941 and steric interaction at lattice point 1051 are positively contributing so the substitution favoring this interaction at that lattice point could yield an active molecule. The correlation plot and contribution plots for model A are given in Figs. 3 and 4 , respectively. 3QSAR model (kNN-MFA) 4.2.1. Electrostatic field (a) Negative range indicates that negative electrostatic potential is favorable for increase in the activity and hence a relatively more electronegative substitution is preferred in that region. (b) Positive range indicates that positive electrostatic potential is favorable for increase in the activity and hence a relatively less electronegative substitution is preferred in that region.
Interpretation of
Steric field
(a) Negative range indicates that negative steric potential is favorable for increase in the activity and hence a relatively less bulky substituent group is preferred in that region. (b) Positive range indicates that positive steric potential is favorable for increase in the activity and hence a relatively more bulky substituent group is preferred in that region.
Model C is the second model which is selected on the basis of statistical coefficients like q 2 (0.79) and Pred r 2 (0.72). The contributing descriptors for this model are E_722 (À0.2429 to À0.1936), S_834 (30.0000-30.0000), E_313 (0.2465-0.3584) and E_169 (À0.1678 to À0.0940). The negative range of the E_722 (À0.2429 to À0.1936) and E_169 (À0.1678 to À0.0940) (Fig 5) indicates that the substitution involving electron deficient group is preferred in that region that is on R2 and R1, also the positive contribution of S_834 (30.0000-30.0000) indicates the substitution of bulkier groups with less electron density that could yield more active molecules. The lattice point at E_313 (0.2465-0.3584) is positively contributing so the substitutions Figure 6 Correlation plot for 3D-QSAR model C. which are increasing the electron density around these lattice points could give more potential inhibition. The negative range at the lattice point E_169 (À0.1678 to À0.0940) indicates the importance of substitution of electron withdrawing groups in pyrazole ring which can stabilize the ring and also increase the activity of the molecules (Table 3 ). The correlation plot for model C is given in Fig. 6 .
4.2.3. Pharmacophore identification studies using Vlife MDS 3.5 A set of pharmacophore hypothesis was generated using the mole sign module of Vlife MDS 3.5 on the reported inhibitors of phosphodiesterase V. Each hypothesis was found to contain common features like hydrogen bond donor, hydrogen bond acceptor, and positive ionizable, aromatic. Results of pharmacophore identification studies revealed that the hydrogen bond donor, hydrogen bond acceptor, positive ionizable, aromatic features are important for the activity. The results of pharmacophore identification studies are given in Table 4 and Fig. 7 .
Conclusion
In this work we identified the structural requirement of 1-(2-ethoxyethyl)-1H-pyrazolo [4,3-d] pyrimidines for the inhibition of phosphodiesterase V. The two different QSAR models are generated by using two different principles, both the models are showing similar results which indicate that this kNN-MFA technique can be utilized for cross validation of the results of multiple linear regression studies. Figure 7 Pharmacophore features of molecules.
